<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01088087</url>
  </required_header>
  <id_info>
    <org_study_id>GangnamSH</org_study_id>
    <nct_id>NCT01088087</nct_id>
  </id_info>
  <brief_title>Effect of Colostrum on Gut Permeability and Endotoxin Level in Chronic Alcoholic Disease</brief_title>
  <official_title>Effect of Colostrum Administration on Improving Gut Permeability and Serum Endotoxin Level in Chronic Alcohol Drinkers With Hepatic Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gangnam Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cell Biotech Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Gangnam Severance Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic alcohol ingestion is related with leaky gut syndrome. Colostrum is well-studied that
      it has a effect of decreasing the degree of leaky gut syndrome.

      So the investigators are planning to find out whether Colostrum has a effect of decreasing
      the degree of leaky gut syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We randomly sort the participant as placebo group and colostrum group. Each group consists of
      17 people. and the duration of our study for one participant is 3 weeks. (Participant takes
      colostrum for 3 weeks.)

      When a person gets leaky gut syndrome, his or her endotoxin and lactulose/mannitol ratio (L/M
      ratio, in urine) can elevate.

      So We will compare the value of those two parameters and LFT. etc. after the administration
      of colostrum or placebo.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">September 2010</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>endotoxin</measure>
    <time_frame>1st visit and 3 weeks after 1st visit</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>lactulose/mannitol ratio</measure>
    <time_frame>3 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Leaky Gut Syndrome</condition>
  <arm_group>
    <arm_group_label>Colostrum</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sugar pill</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>colostrum</intervention_name>
    <description>colostrum, 2g, 2 times a day, for 3 weeks</description>
    <arm_group_label>Colostrum</arm_group_label>
    <other_name>Mucoba</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men aged over 20 who's alcohol consumption per day is 20.0gram average

               -  He must agree to participate this trial voluntarily.

          -  Liver function test within 3 months :

        AST more than 30 or ALT more than 33 or Gamma-GT more than 46

          -  Men who have result of Ultra-sono result of abdomen without Liver cirrhosis

        Exclusion Criteria:

          -  Hepatitis B or C , liver cirrhosis patient

          -  Men who have undergo bowel operation

          -  Men who are taking NSAIDs

          -  Periodontitis or GERD or other G-I tract infection within 2 weeks before enrollment

          -  Men who have been given anticancer drug within one year

          -  Men who have been given antibiotics within 2 weeks

          -  Creatinine level &gt;= 1.4mg/dl

          -  Men who are taking G-I motility drugs or anti-ulcer drug

          -  Milk allergy
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jae Yong Shim, Master</last_name>
    <role>Study Director</role>
    <affiliation>Gangnam Severance Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jae Yong Shim, Master</last_name>
    <phone>82-02-2019-3155</phone>
    <email>hongbai96@yuhs.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hong Bae Kim, Bachelor</last_name>
    <phone>82-02-584-2823</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gangnam Severance Hospital : Family medicine department</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae Yong Shim, Master</last_name>
      <phone>82-02-2019-3155</phone>
      <email>hongbai96@yuhs.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Hong Bae Kim, Bachelor</last_name>
      <phone>82-02-584-2823</phone>
    </contact_backup>
    <investigator>
      <last_name>Hong Bae Kim, Bacholer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2010</study_first_submitted>
  <study_first_submitted_qc>March 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2010</study_first_posted>
  <last_update_submitted>March 16, 2010</last_update_submitted>
  <last_update_submitted_qc>March 16, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 17, 2010</last_update_posted>
  <responsible_party>
    <name_title>Yonsei University</name_title>
    <organization>Gangnam Severance Hospital</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

